Chargement en cours...

PARP inhibitors in breast and ovarian cancer with BRCA mutations: a meta-analysis of survival

Objective: To evaluate the efficacy of poly ADP ribose polymerase (PARP) inhibitors (PARPis) in breast and ovarian cancer with BRCA (BReast CAncer susceptibility gene) mutation (BRCAm). Methods: We conducted a meta-analysis of randomized controlled, phase II or III trials by searching of electronic...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Aging (Albany NY)
Auteurs principaux: Shao, Fengping, Duan, Yaoyun, Zhao, Yunhe, Li, Yinguang, Liu, Jun, Zhang, Cai, He, Shanyang
Format: Artigo
Langue:Inglês
Publié: Impact Journals 2021
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8034970/
https://ncbi.nlm.nih.gov/pubmed/33705352
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.202724
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!